Biogen Inc. CEO Chris Viehbacher has indicated that a successful Alzheimer’s trial for Novo Nordisk A/S’s weight-loss drug could not only complement his company’s...
The emergence of weight loss medications, particularly GLP-1 receptor agonists, is offering new hope for women suffering from polycystic ovary syndrome (PCOS), a hormonal...